Why Inventiva (IVA) Stock Is Trading Higher Premarket Today

Inventiva SA (NASDAQ: IVA) announced the topline results of Phase 2 clinical study evaluating lanifibranor in patients with NAFLD and 

Related Keywords

, Intra Hepatic Triglycerides , Inventiva To Change Clinical Development , Kits Lead ,